Baxter International
Contents
Overview
Baxter International is an American healthcare company based in Deerfield, Illinois, USA[1] .It was founded in 1931, and as of July 2016 employs over 10,000 staff.[2] The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. Baxter has two global business units: Hospital Products and Renal.[3]
Controversies
Tax Evasion and Lobbying
In December 2011, the non-partisan organization Public Campaign criticized Baxter for spending $10.45 million on lobbying and not paying any taxes during 2008–2010, instead getting $66 million in tax rebates, despite making a profit of $926 million.[4] The full Public Campaign report 'For Hire: Lobbyists or the 99%? How Corporations Pay More for Lobbyists Than in Taxes' can be viewed here.
People
Key people at Baxter, as listed on www.baxter.com. Correct as of 11 July 2016.[5]
Board of Directors
- José Almeida - Chairman and Chief Executive Officer, Baxter International Inc.
- Thomas Chen - Former Senior Vice President and President, International Nutrition, Abbott Laboratories.
- Uma Chowdhry -Former Senior Vice President and Chief Science and Technology Officer, E.I. DuPont de Nemours & Company.
- John Forsyth - Chairman and Chief Executive Officer, Wellmark Blue Cross and Blue Shield.
- James R. Gavin III - Chief Executive Officer and Chief Medical Officer, Healing Our Village, Inc.
- Peter Hellman - Former President, Chief Financial and Administrative Officer, Nordson Corporation.
- Munib Islam - Partner and Head of Equities Research, Third Point LLC.
- Michael Mahoney - Chairman, President and Chief Executive Officer, Boston Scientific Corporation.
- Carole Shapazian - Former Executive Vice President, Maytag Corporation.
- Thomas Stallkamp - Lead Director and Founder and Principal, Collaborative Management LLC.
- K. J. Storm - Former Chairman of the Executive Board, AEGON N.V. (The Netherlands).
- Albert Stroucken - Former Executive Chairman and Chief Executive Officer, Owens-Illinois, Inc.
Executive Officers
- osé Almeida - Chairman of the Board and Chief Executive Officer.
- Brik Eyre - Corporate Vice President and President, Hospital Products.
- Robert Felicelli - Corporate Vice President, Business Transformation.
- Jeanne Mason - Corporate Vice President, Human Resources.
- James Saccaro - Corporate Vice President and Chief Financial Officer.
- Marcus Schabacker - Corporate Vice President and Chief Scientific Officer.
- David Scharf - Corporate Vice President and General Counsel.
- Paul Vibert - Corporate Vice President and President, International.
Corporate Officers
- Scott Bohaboy - Corporate Vice President, Treasurer and Head of Global Planning.
- Caroline Karp - Corporate Vice President and Controller.
- Paul Martin - Corporate Vice President and Chief Information Officer.
- Ellen McKintosh - Corporate Vice President, Associate General Counsel and Corporate Secretary.
Affiliations
- Baxalta - Founded on 1 July 2015 after its parent company, Baxter International, spun off the biopharmaceutical division.[6] Baxalta merged with Shire in a $32 billion deal in January 2016.[7]
Science Media Centre donor
Baxter is a former donor to the Science Media Centre according to the SMC website.[8]
Contact
- Corporate Headquarters
- Baxter International Inc.
- One Baxter Parkway
- Deerfield, IL 60015
- Telephone: (224)948-2000
- www.baxter.com
Resources
- Baxter International website.
- Public Campaign report - For Hire: Lobbyists or the 99%? How Corporations Pay More for Lobbyists Than in Taxes.
Notes
- ↑ Baxter contact info, Baxter website, accessed 11 July 2016.
- ↑ Baxter International, Baxter LinkedIn page, accessed 11 July 2016.
- ↑ 'Corporate Overview', Baxter International, accessed 11 July 2016.
- ↑ Ashley Portero, [http://www.webcitation.org/64D9GyQG0 '30 Major U.S. Corporations Paid More to Lobby Congress Than Income Taxes, 2008–2010', International Business Times. Archived from the original on December 26, 2011. Last accessed 11 July 2016.
- ↑ Company Leadership, Baxter International website, accessed 11 July 2011.
- ↑ 'Baxalta: A Rare Undervalued Biopharmaceutical Company', CNA Finance, 23 July 2015.
- ↑ 'Shire, Baxalta Tie the Knot in $32B Merger', GEN - Genetic Engineering & Biotechnology News, 11 January 2016.
- ↑ Science Media Centre funding, Science Media Centre website, accessed 11 July 2011.
